Skip to Content

This Centrifuge Costs 20 Cents to Make and Can Be Used Anywhere

Modeled on a children’s toy, the Paperfuge can spin at up to 125,000 RPMs and doesn’t need electricity.
January 10, 2017

It may look like a toy, but a centrifuge made out of paper could dramatically cut the cost of analyzing blood and diagnosing diseases like malaria in places where standard medical equipment is hard to come by.

The device, called the Paperfuge, is described today in the journal Nature Biomedical Engineering. Researchers at Stanford University led by Manu Prakash built it using essentially just paper discs, some string, and tiny straws to hold a blood sample (the team also 3-D printed a plastic version). By twisting up the string and tugging on the device, it spins at up to 125,000 revolutions per minute. A minute-and-a-half of spinning is enough to separate plasma from whole blood, and 15 minutes of work will isolate malaria parasites if they’re present.

Prakash, who in 2014 was named to our list of 35 Innovators Under 35, is a pioneer in frugal science, a field that aims to develop inexpensive tools that enable important and often lifesaving work—with a focus on some of the world’s largest public health challenges. Prakash has developed a microfluidic chemistry lab that costs less than $5 as well as a microscope made of just 55 cents worth of materials. Like centrifuges, microscopes are key tools for diagnosing malaria, which can improve treatment for people who get sick.

(Read more: “35 Innovators Under 35: Manu Prakash”)

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.